The National Institutes of Health (NIH) has awarded a group of researchers $2.87 million for preclinical development of an oral drug to treat Shigella and C. difficile.
Shigella is a bacterium that belongs to a small group of pathogens (including E. coli O157:H7 and Cryptosporidium) that can infect the gut after the ingestion of
CBC.ca reports that the C. difficile outbreak at a Quebec hospital in St-Hyacinthe has killed another person, bringing the death toll to 10 since the bacteria emerged at the health centre in July.
A total of 25 people have been infected with C. difficile, which causes severe diarrhea, at the Centre hospitalier Honoré-Mercier in St-Hyacinthe